Is LUV Stock a Buy, Sell or Hold?
Southwest Airlines (NYSE:LUV) is one of America’s major air transportation…
Sell
6
ZVSA Quote, Financials, Valuation and Earnings
Last price:
$0.65
Seasonality move
:
-39.77%
Day range:
$0.58 - $0.61
52-week range:
$0.58 - $8.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.17x
Volume:
58.8K
Avg. volume:
299.5K
1-year change:
-91.94%
Market cap:
$1.5M
Revenue:
--
EPS (TTM):
-$113.75
Earnings Data
Next earnings date for ZVSA
--
Most recent earnings per share
-$0.57
Missed by $0.57
(Dec 31/2024)
Consensus Estimate
--
(Dec 31/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ZVSA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | -- | -- | -- | -$0.40 | -- |
| 12/31/2024 | Q4 | -- | -- | -$0.57 | -- | -- |
| 09/30/2024 | Q3 | -- | -- | -$2.43 | -$1.60 | -$0.83 |
| 06/30/2024 | Q2 | -- | -- | -$33.10 | -$3.75 | -$29.35 |
| 03/31/2024 | Q1 | -- | -- | -$45.30 | -$3.70 | -$41.60 |
| 12/31/2023 | Q4 | -- | -- | -$32.92 | -$21.40 | -$11.52 |
| 09/30/2023 | Q3 | -- | -- | -$30.18 | -$56.00 | $25.82 |
| 06/30/2023 | Q2 | -- | -- | -$1,694.12 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$1,358.80 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$177.37 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$515.54 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$35.00 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$54.17 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$28.45 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$27.16 | -- | -- |
ZyVersa Therapeutics Earnings Questions
-
How Much did ZyVersa Therapeutics Generate in Revenue Last Quarter?
ZyVersa Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did ZyVersa Therapeutics Beat Earnings Last Quarter?
ZyVersa Therapeutics announced earnings per share of -$0.57 which represents a miss of analyst forecast a -- per share.
-
Is ZyVersa Therapeutics Profitable?
ZyVersa Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for ZyVersa Therapeutics EPS Next Year?
ZyVersa Therapeutics's earnings are forecast to decrease from -$8.48 per share to -$12.43 per share next year representing a decrease of -98.86%.
-
When is ZyVersa Therapeutics's Earnings Date?
Currently, ZyVersa Therapeutics has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on July 3, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
43
MNPR alert for Apr 3
Monopar Therapeutics [MNPR] is down 10.04% over the past day.
Buy
75
BKTI alert for Apr 3
BK Technologies [BKTI] is down 7.68% over the past day.
Sell
34
SWTX alert for Apr 3
SpringWorks Therapeutics [SWTX] is down 7.29% over the past day.
